Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -27.94%-11.33K | -557.72%-7.64K | -322.36%-33.66K | 19.72%-17.7K | 61.02%-2.54K | 8.28%-8.86K | 128.55%1.67K | -44,172.22%-7.97K | -18,908.62%-22.05K | -36,144.44%-6.52K |
| Net income from continuing operations | 8.68%-2.95K | -486.18%-9.24K | -77.13%-6.18K | -27.57%-29.61K | -216.28%-21.31K | 13.95%-3.23K | 81.09%-1.58K | 20.36%-3.49K | 8.75%-23.21K | 30.14%-6.74K |
| Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --19.18K | ---- |
| Change In working capital | -48.90%-8.39K | -50.72%1.6K | -513.44%-27.48K | 928.07%11.91K | 8,630.70%18.77K | 4.69%-5.63K | 30.40%3.25K | -202.64%-4.48K | -95.43%1.16K | -97.77%215 |
| -Change in receivables | -35.19%-146 | 1,165.74%1.15K | ---246 | ---1.47K | ---1.26K | ---108 | ---108 | --0 | --0 | --0 |
| -Change in prepaid assets | --0 | ---- | ---- | --42 | --0 | --0 | ---- | ---- | --0 | --0 |
| -Change in payables and accrued expense | -49.17%-8.24K | -86.45%449 | -507.95%-27.23K | 1,051.73%13.34K | 9,215.81%20.03K | 6.51%-5.53K | 33.05%3.31K | -202.64%-4.48K | -95.43%1.16K | -97.77%215 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -27.94%-11.33K | -557.72%-7.64K | -322.36%-33.66K | -516.12%-17.7K | -120.10%-2.54K | 8.28%-8.86K | 128.55%1.67K | -44,172.22%-7.97K | -2,376.72%-2.87K | 70,394.44%12.65K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -95.05%289 | -166.40%-1.17K | 569.95%53.27K | -5.72%18.08K | -61.20%2.53K | -14.61%5.84K | 1.77K | 7.95K | 19.18K | 6.51K |
| Net common stock issuance | --0 | --0 | --107.95K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | -95.05%289 | -166.40%-1.17K | -787.74%-54.68K | -5.72%18.08K | -61.20%2.53K | -14.61%5.84K | --1.77K | --7.95K | --19.18K | --6.51K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -95.05%289 | -166.40%-1.17K | 569.95%53.27K | -5.72%18.08K | -61.20%2.53K | -14.61%5.84K | --1.77K | --7.95K | --19.18K | --6.51K |
| Net cash flow | ||||||||||
| Beginning cash position | 219.93%11.28K | 21,747.83%20.1K | 345.45%490 | -96.31%110 | 296.88%508 | 19.68%3.53K | -96.90%92 | -96.31%110 | -3.74%2.98K | -95.73%128 |
| Current changes in cash | -265.85%-11.05K | -356.65%-8.82K | 109,044.44%19.61K | 113.23%380 | 0.00%-18 | -7.09%-3.02K | 19,183.33%3.44K | 0.00%-18 | -2,376.72%-2.87K | 0.00%-18 |
| End cash Position | -52.95%239 | 219.93%11.28K | 21,747.83%20.1K | 345.45%490 | 345.45%490 | 296.88%508 | 19.68%3.53K | -96.90%92 | -96.31%110 | -96.31%110 |
| Free cash from | -27.94%-11.33K | -557.72%-7.64K | -322.36%-33.66K | -516.12%-17.7K | -120.10%-2.54K | 8.28%-8.86K | 128.55%1.67K | -44,172.22%-7.97K | -2,376.72%-2.87K | 70,394.44%12.65K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.